stockmarketproxy
/
JAZZNasdaq SEC EDGAR

Jazz Pharmaceuticals plc

Pharmaceutical Preparations·DUBLIN·FY end 12/31·CIK 1232524
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

12 members · 11 independent · FY 2024
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Jennifer E. CookDirector5y59Comp$534,265
Patrick G. EnrightDirector16y63AuditComp$525,073
Seamus MulliganDirector13y64SMCTransaction Committee$530,073
Norbert G. Riedel, Ph.D.Director12y67SMCNCG$533,179
Bruce C. CozaddCEO and Chair22y61
Laura J. HamillDirector1y60Comp$460,602
Patrick KennedyDirector1y56AuditTransaction Committee$675,388
Heather Ann McSharryDirector12y63NCGAuditTransaction Committee$542,573
Kenneth W. O'KeefeDirector21y58Audit$512,573
Anne O'RiordanDirector6y57AuditComp$523,660
Mark D. Smith, M.D.Director5y73NCGSMC$520,073
Rick E WinninghamLead Independent Director15y65NCGSMC$570,073

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.